Dermata Therapeutics (DRMA) Q1 2025 Earnings

17MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-5.4
-3.76
-2.11
-0.47

Details

Expected EPS
-1.5
Actual EPS
-1.34
Surprise EPS
0.16
Surprise Percent
+10.67%

Description

Dermata Therapeutics (DRMA) has reported earnings of -1.34 per share for Q1 2025.

0 Comments

Share your thoughts